PIXLUMI Trademark
Trademark Overview
On Wednesday, June 4, 2025, a trademark application was filed for PIXLUMI with the United States Patent and Trademark Office. The USPTO has given the PIXLUMI trademark a serial number of 79428134. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 2, 2026. This trademark is owned by Telix Pharmaceuticals Limited. The PIXLUMI trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing, monitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing, monitoring and treatment of cancer
Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use
General Information
| Serial Number | 79428134 |
| Word Mark | PIXLUMI |
| Filing Date | Wednesday, June 4, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, June 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 2, 2026 |
Trademark Statements
| Pseudo Mark | PIX LUMI |
| Goods and Services | Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing, monitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing, monitoring and treatment of cancer |
| Goods and Services | Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 30, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Telix Pharmaceuticals Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Party Name | Telix Pharmaceuticals Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | AU |
Trademark Events
| Event Date | Event Description |
| Thursday, July 17, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, July 30, 2025 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, August 1, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 1, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, August 26, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, September 3, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, September 4, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, October 20, 2025 | REFUSAL PROCESSED BY MPU |
| Monday, October 20, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, November 7, 2025 | REFUSAL PROCESSED BY IB |
| Thursday, January 1, 2026 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, January 22, 2026 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, April 17, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 17, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 17, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 5, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 27, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 2, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 2, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
